Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysis
Abstract Bispecific antibodies (BiTEs) have transformed the therapeutic landscape of relapsed/refractory multiple myeloma (RRMM), offering deep and durable responses even in heavily pretreated patients. However, their use carries substantial infectious risk due to immunosuppression, particularly hyp...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2026-04-01
|
| Edice: | Annals of Hematology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s00277-026-07026-9 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|